Meta tags:
author= ESMO;
keywords= medical oncology,oncologists,oncology societies,oncology conferences,europe;
description= ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.;
Headings (most frequently used words):
esmo, 2024, in, cancer, to, of, and, with, the, for, congress, on, cancers, oncology, rare, new, treatment, patients, preceptorship, attend, or, promise, are, benefit, care, reasons, lung, metastatic, screening, indications, should, gastrointestinal, 2023, studies, combination, you, two, pembrolizumab, breast, sarcoma, fellowship, not, colorectal, fda, be, course, next, approves, urothelial, provide, health, your, advanced, tumour, stage, evidence, european, lugano, now, shows, nsclc, medical, targeted, from, increasing, large, meaningful, palliative, clinically, demonstrate, continues, who, adjuvant, carcinoma, research, show, supportive, unresectable, resected, gemcitabine, nivolumab, helsinki, use, tests, dmfs, active, call, non, society, register, america, latin, summit, immuno, ichno, december, iib, manifesto, other, work, this, an, eu, therapeutic, plan, award, iic, melanoma, cisplatin, recipient, stable, different, as, imatinib, also, continued, support, state, further, disease, early, steps, gep, why, still, sarcomas, necs, can, what, centralisation, gist, life, tumours, announced, women, treatments, career, desmoid, types, nirogacestat, quality, clinical, niche, improves, localized, art, malignancies, education, meetings, sao, best, options, bladder, strategies, paulo, courses, journals, publications, subscribe, kidney, perioperative, day, up, areas, gender, equity, advancing, commission, lancet, partners, people, vaccination, outlining, key, 19, directions, covid, statements, three, wake, twenty, releases, renewed, unleash, been, potential, beating, universal, coverage, study, availability, anti, medicines, must, future, their, hong, 172, students, applying, submit, become, member, membership, 35k, collaboration, 40, powerful, give, others, jordan, apply, 2026, cervantes, thinking, would, like, post, examination, by, offered, looking, esmobreast24, path, improve, development, community, international, top, dent, collaborate, kong, medicine, invitation, gallery, video, workshop, methods, essen, nuclear, maio, applications, diagnostic, eanm, valencia, china, sar, president, marabelle, network, legal, opportunity, excellent, event, at, experience, share, kfoury, bayona, sanchez, esmogynae24, useful, links, invite, svane, has, obesity, relations, phaeochromocytomas, chemotherapy, compared, vedotin, enfortumab, survival, paragangliomas, sunitinib, untreated, efficacy, resectable, neoadjuvant, include, extension, recommends, previously, locally, diagnosis, cell, naïve, os, prolong, does, resection, primary, small, amivantamab, mutated, insertion, 20, exon, egfr, vmjw, ema, after, colon, may, resources, webinar, practice, mtb, mcbs, finland, 23, news, 22, abstracts, plenaries, virtual, academy, elcc, latest, brca, sexual, analysis, poor, report, most, immunotherapy, response, monitoring, biopsy, mutations, liquid, multimodal, mcrpc, outcomes, worse, associated, iv, amenable, official, countries, enters, survivors, rights, financial, equal, ensure, calls, heine, forgotten, right, policy, public, effective, into, era, translating, chair, actor, status, special, honorary, tat, appointments, groups, hansen, working, committees, open, awards, process, nomination, scientific, singapore, curative, syndrome, 26, therapies, anticancer, capecitabine, oral, treated, foot, february, hand, incidence, reduces, gel, diclofenac, topical, 28, paris, adults, asia, switzerland, geneva, young, france, among, rates, bowel, increases, contributing, alcohol, newsletters,
Text of the page (most frequently used words):
#esmo (208), the (146), 2024 (109), and (99), #cancer (87), for (65), #oncology (62), #covid (40), cancers (39), mar (37), #with (33), congress (29), #society (28), 2023 (27), #rare (27), #care (24), news (22), updates (20), daily (19), reporter (19), clinical (18), working (18), from (17), press (17), group (17), patients (17), #research (16), committee (16), award (15), treatment (15), all (15), era (14), preceptorship (14), courses (13), study (13), lung (13), more (13), #releases (13), feb (12), medical (12), about (12), guidelines (12), your (12), are (12), studies (11), now (11), european (11), open (11), course (10), sarcoma (10), world (10), our (10), mcbs (9), advanced (9), malignancies (9), meeting (9), 2022 (9), this (9), policy (8), can (8), palliative (8), events (8), cookies (8), new (8), patient (8), metastatic (8), breast (8), may (8), benefit (8), task (8), evidence (8), funding (8), findings (8), tumours (8), that (8), early (8), pandemic (7), class (7), supportive (7), fellowship (7), use (7), force (7), registration (7), two (7), promise (7), gastrointestinal (7), online (7), health (7), jul (7), 2019 (7), event (7), sessions (7), member (7), scientific (7), how (7), day (7), benefits (7), you (7), lugano (7), tumour (7), resources (7), their (6), attend (6), lymphoma (6), not (6), haematological (6), cell (6), primary (6), non (6), young (6), experts (6), analysis (6), reasons (6), site (6), centres (6), latest (6), development (6), melanoma (5), pembrolizumab (5), head (5), medicines (5), journals (5), jan (5), medicine (5), urothelial (5), should (5), carcinoma (5), career (5), state (5), during (5), gist (5), neck (5), oncologists (5), after (5), meetings (5), annals (5), 2021 (5), membership (5), board (5), members (5), virtual (5), based (5), results (5), will (5), who (5), efficacy (5), different (5), women (5), facebook (5), immuno (5), announcement (5), give (4), exam (4), questions (4), webinar (4), groups (4), shows (4), management (4), nsclc (4), roundtable (4), asia (4), work (4), opportunities (4), specialists (4), testimonials (4), demonstrate (4), resected (4), combination (4), its (4), chemotherapy (4), examination (4), further (4), sources (4), support (4), improve (4), colorectal (4), read (4), apply (4), indications (4), educational (4), release (4), discover (4), oct (4), switzerland (4), targeted (4), designated (4), calling (4), general (4), public (4), anticancer (4), annual (4), action (4), why (4), screening (4), call (4), announced (4), genitourinary (4), register (4), series (4), field (4), imatinib (4), second (3), bladder (3), paulo (3), fda (3), w4o (3), sao (3), stage (3), tools (3), next (3), coverage (3), increasing (3), practice (3), also (3), provide (3), best (3), prostate (3), december (3), nomination (3), settings (3), burden (3), pocket (3), track (3), dec (3), discuss (3), present (3), resilience (3), therapies (3), resource (3), faqs (3), education (3), 2020 (3), centre (3), treated (3), calendar (3), publications (3), key (3), achievements (3), app (3), march (3), awards (3), manifesto (3), process (3), europe (3), major (3), approves (3), plenaries (3), precision (3), outcomes (3), programme (3), calls (3), innovative (3), sarcomas (3), held (3), post (3), has (3), treatments (3), leaders (3), get (3), acknowledgements (3), collaborate (3), prominent (3), phase (3), essential (3), become (3), reference (3), editorial (3), molecular (3), hodgkin (3), oncologypro (3), trial (3), life (3), following (3), worldwide (3), diagnosis (3), multiple (3), reported (3), into (3), login (3), first (3), contact (3), what (3), change (3), tests (3), other (3), global (3), helsinki (3), summit (3), partners (3), observatory (3), high (3), president (3), myeloma (3), hansen (3), neuroendocrine (3), heine (3), gynaecological (3), survival (3), academy (3), spain (3), eha (3), art (3), application (3), risk (3), final (3), students (3), information (3), tat (3), glossary (3), current (3), honorary (3), durante (2), aggressive (2), right (2), cervical (2), personalised (2), pandemia (2), explained (2), survivors (2), france (2), small (2), challenges (2), endometrial (2), time (2), forgotten (2), financial (2), brain (2), climate (2), guides (2), madrid (2), save (2), advances (2), still (2), improves (2), nirogacestat (2), desmoid (2), occurring (2), was (2), symptom (2), reduction (2), defi (2), hoc (2), niche (2), place (2), stable (2), efforts (2), sustaining (2), steps (2), centralisation (2), expedite (2), implementation (2), collaborations (2), border (2), cross (2), increased (2), quality (2), disease (2), continued (2), gep (2), immunotherapy (2), access (2), solid (2), response (2), genomics (2), most (2), suggests (2), guided (2), sexual (2), necs (2), failure (2), explore (2), gastroenteropatic (2), carcinomas (2), effect (2), synergic (2), irinotecan (2), lurbinectedin (2), types (2), active (2), realised (2), theranostics (2), adcs (2), models (2), optimise (2), scale (2), hub (2), live (2), abstracts (2), gain (2), immediate (2), visibility (2), unknown (2), together (2), paris (2), advocates (2), past (2), adults (2), among (2), rce (2), rates (2), predict (2), geneva (2), nov (2), mission (2), april (2), until (2), uninterrupted (2), checkmate (2), show (2), large (2), blue (2), eclipse (2), unresectable (2), gemcitabine (2), cisplatin (2), nivolumab (2), 901 (2), iic (2), magnitude (2), iib (2), dmfs (2), meaningful (2), clinically (2), continues (2), adjuvant (2), 716 (2), keynote (2), free (2), metastasis (2), distant (2), hepatocellular (2), knowledge (2), committees (2), countries (2), host (2), include (2), workshops (2), institutes (2), fellowships (2), assembly (2), external (2), code (2), session (2), consensus (2), structure (2), recommendations (2), executive (2), elections (2), corner (2), summits (2), faculty (2), recertification (2), requirements (2), years (2), five (2), over (2), translational (2), rights (2), terms (2), newsletters (2), useful (2), workshop (2), availability (2), national (2), universal (2), digital (2), data (2), potential (2), apr (2), finland (2), therapeutic (2), applications (2), essen (2), germany (2), valencia (2), america (2), latin (2), future (2), hong (2), kong (2), sar (2), china (2), brazil (2), real (2), frequently (2), fellow (2), community (2), plan (2), asked (2), ichno (2), submit (2), forces (2), handbooks (2), slide (2), sets (2), cme (2), out (2), fesmo (2), statements (2), special (2), interest (2), some (2), search (2), privacy (2), ecro (2), vaccines (2), browser (2), vaccination (2), today (2), people (2), pleased (2), announce (2), grants (2), status (2), properly (2), relations (2), official (2), actor (2), these (2), bestowed (2), necessary (2), values (2), renal (2), act (2), others (2), generation (2), experience (2), help (2), gender (2), recipient (2), worse, joining, widest, mtb, oops, join, shoes, page, stepping, categories, footprint, letter, associated, mutations, possible, audience, fees, topic, country, chest, features, mcrpc, expert, understand, version, neuro, assess, chrome, hereditary, using, old, paga, syndromes, endocrine, boards, adaptation, methodologies, asian, sequencing, tool, sep, logo, one, minimal, form, involved, 2025, communication, societies, leadership, iotech, practising, vision, accreditation, opwg, siog, accessible, elderly, adolescents, compliance, audit, council, organisational, lifetime, achievement, seamonkey, declaration, brand, notification, leukemia, reviews, affiliated, google, firefox, nominations, validated, technology, careers, biographies, mozilla, disclosure, reproducible, vote, bylaws, explorer, conduct, internet, opera, safari, apple, faq, efpia, pan, pathways, methodology, jobs, advocacy, line, language, scales, travel, bone, 2018, effects, side, 2017, survivorship, pain, 2016, oncologist, getting, grant, pool, definition, corporate, governance, considering, parallel, sit, talent, certificate, sample, actionability, targets, mora, professional, escat, schemes, cuidado, abroad, pandémie, oesophageal, ovarian, pancreatic, krebstherapie, während, der, pandemie, accredit, integrated, databases, type, database, regulatory, training, cours, del, cure, cáncer, bureaucracy, rationalizing, procedures, bibliography, per, proposals, cancro, traitement, list, families, mobile, nhl, student, sponsors, congresses, elsevier, perspectives, experiences, kols, surveys, registries, registry, cocare, tutorials, adapted, indolent, gastro, weighing, topics, translated, disclaimer, hcc, mcl, update, approaches, dlbcl, therapy, elcc, miss, important, aug, masterclasses, risks, specific, kick, 2030, agenda, involvement, activities, consultations, yo4yo, childcare, responses, policies, networks, jarc, service, portal, off, survey, reorganising, roundtables, wave, eso, known, symposia, unknowable, colloquia, licensed, awardees, full, media, newsroom, offers, joint, reports, brca, moving, personalise, clinicians, czech, republic, prague, visit, library, factsheet, biomarkers, essentials, range, kidney, browsed, downloaded, offline, tech, globally, visible, platform, barcelona, directions, source, netherlands, marabelle, svane, invite, invitation, video, gallery, methods, sint, localized, michielsgestel, jun, eanm, diagnostic, nuclear, berlin, perioperative, strategies, publish, preceptorships, share, beating, centred, approach, close, gap, healthier, outlining, areas, unleash, advisor, must, lancet, commission, advancing, equity, available, they, address, safety, wake, anti, lectures, leading, interactive, discussion, seminars, supporting, decisions, regularly, updated, developed, profession, last, options, observes, anticipates, costs, accessibility, antineoplastic, highlighting, worrying, stall, maio, kfoury, advocate, registered, being, used, instagram, linkedin, rss, youtube, twitter, swiss, profit, providing, organisation, provided, directly, via, ginevra, 6900, copyright, insights, while, sign, disable, enable, core, functionality, website, cannot, function, without, only, them, uses, changing, preferences, accept, reject, customise, detailed, please, check, reserved, receive, bayona, cervantes, watch, videos, esmobreast24, top, international, collaboration, 2026, dent, institutions, jordan, powerful, excellent, opportunity, network, esmogynae24, sanchez, path, chance, account, 172, subscribe, links, cookie, legal, specialties, professionals, 35k, thinking, collegial, applying, main, saturday, october, looking, offered, would, like, participate, interference, strategy, testing, resection, incidence, hand, foot, syndrome, oral, capecitabine, synchronous, ccre, does, gel, prolong, naïve, colon, amenable, curative, papillon, amivantamab, reduces, diclofenac, egfr, bring, stakeholder, focuses, novel, transform, impact, february, renowned, topical, researchers, practitioners, appointment, brings, various, thoracic, torch, vmjw, exon, bowel, fragment, concerns, often, unaddressed, report, poor, kinetics, dna, methylation, quantity, resectable, plasma, multimodal, liquid, biopsy, monitoring, castration, resistant, genetic, however, neoadjuvant, insertion, locally, mutated, 302, enfortumab, vedotin, compared, previously, untreated, firstmappp, extension, sunitinib, phaeochromocytomas, paragangliomas, indicated, adult, recurrence, ema, recommends, multi, increases, booster, target, mandates, january, chair, appointments, enriqueta, felip, likely, drugs, alterations, chairs, cells, less, need, landmark, trials, late, breaking, presentations, started, appointed, opens, organisations, dose, twenty, three, renewal, organization, privilege, granted, governmental, which, newly, recognises, sustained, systematic, engagement, been, renewed, funda, meric, bernstam, enters, doors, contributing, where, across, entire, relevance, level, specifically, pacific, region, singapore, developments, translating, fast, selected, between, component, death, obesity, alcohol, effective, biggest, week, guaranteeing, states, recently, adopted, text, consumer, credits, directive, neighbours, seeking, tackle, credit, called, period, end, ensure, equal, building, strong, political, displaying,
Text of the page (random words):
e the promise of adcs and theranostics realised in different tumours daily reporter desmoid tumours nirogacestat improves quality of life also in stable disease 15 mar 2024 in a post hoc analysis of the defi trial a reduction in symptom burden was reported with benefits occurring early in treated patients daily reporter should rare cancers still be in a niche of oncology 15 mar 2024 esmo is sustaining its efforts to give rare cancers a more prominent place in oncology daily reporter centralisation of care in rare cancers what are the next steps 14 mar 2024 innovative models and increased cross border collaborations can further support the implementation of rare cancer reference centres to expedite diagnosis and improve treatment daily reporter studies provide further evidence to support continued imatinib in two different gist indications 14 mar 2024 uninterrupted imatinib is essential to optimise outcomes in metastatic and high risk resected gist daily reporter brca mutations are associated with worse treatment outcomes in mcrpc 8 mar 2024 in patients with metastatic castration resistant prostate cancer early genetic testing may help personalise treatments in the first line as a study suggests daily reporter a multimodal liquid biopsy analysis shows promise in monitoring response to immunotherapy 5 mar 2024 a study shows that early kinetics in dna methylation and fragment quantity in plasma can predict response to pembrolizumab in patients with advanced solid tumours daily reporter most women report poor sexual health after a diagnosis of breast cancer 1 mar 2024 however patients sexual concerns are often unaddressed in oncology a study suggests read the esmo daily reporter oncology news two large studies with new screening tests show promise for increasing the use of colorectal cancer screening 18 mar 2024 findings from the eclipse and blue c studies daily reporter a new combination treatment shows early promise in gep necs 16 mar 2024 lurbinectedin and irinotecan demonstrate a synergic clinical effect in patients with neuroendocrine carcinomas of gastroenteropatic primary site after chemotherapy failure oncology news fda approves nivolumab in combination with cisplatin and gemcitabine for unresectable or metastatic urothelial carcinoma 15 mar 2024 evidence for efficacy is based on the results from the checkmate 901 study daily reporter can sarcomas benefit from targeted treatments active in other tumour types 15 mar 2024 two studies in sarcoma explore the promise of adcs and theranostics realised in different tumours daily reporter desmoid tumours nirogacestat improves quality of life also in stable disease 15 mar 2024 in a post hoc analysis of the defi trial a reduction in symptom burden was reported with benefits occurring early in treated patients daily reporter should rare cancers still be in a niche of oncology 15 mar 2024 esmo is sustaining its efforts to give rare cancers a more prominent place in oncology daily reporter centralisation of care in rare cancers what are the next steps 14 mar 2024 innovative models and increased cross border collaborations can further support the implementation of rare cancer reference centres to expedite diagnosis and improve treatment daily reporter studies provide further evidence to support continued imatinib in two different gist indications 14 mar 2024 uninterrupted imatinib is essential to optimise outcomes in metastatic and high risk resected gist oncology news adjuvant pembrolizumab continues to demonstrate a clinically meaningful dmfs benefit in patients with resected stage iib or iic melanoma 14 mar 2024 findings from the final distant metastasis free survival analysis of keynote 716 study read the esmo daily reporter more oncology news more press releases more society updates oncology news two large studies with new screening tests show promise for increasing the use of colorectal cancer screening 18 mar 2024 findings from the eclipse and blue c studies oncology news fda approves nivolumab in combination with cisplatin and gemcitabine for unresectable or metastatic urothelial carcinoma 15 mar 2024 evidence for efficacy is based on the results from the checkmate 901 study oncology news adjuvant pembrolizumab continues to demonstrate a clinically meaningful dmfs benefit in patients with resected stage iib or iic melanoma 14 mar 2024 findings from the final distant metastasis free survival analysis of keynote 716 study oncology news ema recommends extension of therapeutic indications for pembrolizumab to include neoadjuvant treatment of resectable nsclc 13 mar 2024 it is indicated in adult patients at high risk for recurrence oncology news efficacy of sunitinib in patients with metastatic phaeochromocytomas and paragangliomas 12 mar 2024 findings from the firstmappp study oncology news survival benefit of enfortumab vedotin and pembrolizumab compared with chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer 11 mar 2024 findings from the ev 302 study oncology news fda approves amivantamab vmjw for egfr exon 20 insertion mutated non small cell lung cancer indications 8 mar 2024 evidence for efficacy is based on the results from the papillon study oncology news primary tumour resection does not prolong os in patients with treatment naïve stage iv colon cancer not amenable for curative treatment 7 mar 2024 findings from the analysis of synchronous and ccre iv studies oncology news topical diclofenac gel reduces the incidence of hand foot syndrome in patients treated with oral capecitabine 6 mar 2024 findings from the d torch study more oncology news press releases event announcement european lung cancer congress 2024 7 mar 2024 the european lung cancer congress 2024 is the annual appointment that brings together various experts in the field of thoracic oncology press releases event announcement esmo sarcoma and rare cancers congress 2024 5 mar 2024 the esmo sarcoma and rare cancers congress 2024 will be held in lugano from 14 to 16 march and will bring together world renowned experts among researchers and practitioners to present and discuss the latest advances in the treatment and care of sarcoma and rare cancers in general press releases event announcement esmo targeted anticancer therapies congress 2024 26 28 february paris france 20 feb 2024 the esmo targeted anticancer therapies congress 2024 is the annual multi stakeholder meeting that focuses on the development of novel anticancer therapies and how this can transform the current knowledge and impact clinical care press releases annals of oncology press release obesity and alcohol are contributing to increases in bowel cancer rates among young adults 29 jan 2024 experts predict death rates from all cancers for the eu and uk for 2024 press releases event announcement esmo immuno oncology congress 2023 6 8 december 2023 geneva switzerland 29 nov 2023 the esmo immuno oncology congress 2023 where experts discuss the latest scientific developments in this fast moving field of cancer treatment will be held in geneva switzerland between 6 8 december also with a virtual component press releases event announcement esmo asia congress 2023 1 3 december 2023 singapore 24 nov 2023 the esmo asia congress 2023 is the annual meeting to present and discuss the latest scientific and clinical advances across the entire field of oncology of relevance at a global level and specifically for the asia pacific region press releases esmo congress 2023 press release esmo manifesto translating scientific evidence into effective public health policy 20 oct 2023 evidence is building up that strong political action has the potential to tackle two of our era s biggest challenges climate change and the increasing burden of cancer on society press releases esmo congress 2023 press release the right to be forgotten esmo calls on eu countries to ensure equal financial rights for cancer survivors 18 oct 2023 as the esmo congress 2023 opens its doors in madrid this week esmo calls all eu member states to act on the recently adopted final text of the eu consumer credits directive by following their european neighbours spain and france and guaranteeing cancer survivors seeking financial credit the so called right to be forgotten after a period of five years following the end of their treatment press releases esmo congress 2023 press release lung cancer treatment research enters a new era 17 oct 2023 more people with non small cell lung cancer nsclc are likely to benefit from new drugs that target molecular alterations in tumour cells with less need for chemotherapy following results of multiple landmark clinical trials reported for the first time in late breaking presentations at the esmo congress 2023 more press releases society updates society updates 2024 heine h hansen award recipient announced 5 mar 2024 the european society for medical oncology esmo announced today that the 2024 heine h hansen award is bestowed to enriqueta felip society updates nomination process for the 2024 esmo society awards now open 5 mar 2024 the nomination process for the 2024 esmo society awards is now open society updates society updates esmo committees and working groups new chair appointments 6 feb 2024 esmo is pleased to announce the newly appointed committee and working group chairs who started their mandates in january 2024 society updates society updates 2024 tat honorary award recipient announced 6 feb 2024 the european society for medical oncology esmo has announced today that the 2024 esmo tat honorary award is bestowed to funda meric bernstam society updates society updates esmo s special status as non state actor in official relations with who has been renewed 5 feb 2024 esmo is pleased to announce the renewal of its status as non state actor in official relations with the world health organization a privilege granted to non governmental organisations which recognises esmo s sustained and systematic engagement in the interest of the who society updates esmo releases twenty three new statements on covid 19 vaccination in people with cancer 16 dec 2021 based on current knowledge available they address key questions on safety and efficacy of covid 19 vaccines their interference with anticancer treatment and advocate for a global strategy for the booster dose society updates esmo partners with the lancet commission on women and cancer to advancing gender equity in cancer 7 dec 2021 esmo president will act as an advisor society updates society updates the esmo manifesto outlining key areas to unleash the potential of the eu beating cancer plan 4 feb 2024 an evidence based and patient centred approach to close the care gap for a healthier europe society updates society updates universal health coverage day esmo s study on the availability of anti cancer medicines must work as a wake up call 12 dec 2023 as the world observes universal health coverage day esmo anticipates the results of the latest study on the availability out of pocket costs and accessibility of antineoplastic medicines highlighting a worrying stall over the last five years more society updates education esmo clinical practice guidelines provide your patients with the best care options supporting your clinical decisions with esmo s regularly updated clinical practice guidelines and consensus recommendations developed by the leading experts in our profession read the guidelines esmo courses 10 jul 2019 the courses include state of the art lectures workshops and interactive discussion seminars preceptorships courses on medical oncology for medical students advanced courses summits esmo oncology journals 10 jul 2019 a globally visible platform to publish scientific studies and a source of educational updates annals of oncology esmo open esmo io tech more about journals publications 10 jul 2019 a range of publications that can be browsed online by all esmo members and downloaded for offline use essentials for clinicians handbooks factsheet on biomarkers visit the education library next meetings esmo preceptorship course 20 mar 2024 sao paulo brazil esmo preceptorship on breast cancer 2024 sao paulo esmo congress 20 mar 2024 prague czech republic european lung cancer congress 2024 esmo congress 21 mar 2024 barcelona spain ichno 2024 esmo summit 22 mar 2024 sao paulo brazil esmo summit latin america 2024 esmo preceptorship course 3 apr 2024 lugano switzerland esmo preceptorship on metastatic bladder and kidney cancer 2024 lugano esmo advanced course 20 apr 2024 hong kong sar china esmo advanced course on perioperative strategies in localized malignancies state of the art and future directions in lung cancer 2024 hong kong sar china esmo preceptorship course 3 may 2024 lugano switzerland esmo preceptorship on supportive and palliative care 2024 lugano esmo preceptorship course 3 may 2024 valencia spain esmo preceptorship on colorectal cancer 2024 valencia esmo congress 15 may 2024 berlin germany esmo breast cancer 2024 esmo advanced course 22 may 2024 essen germany esmo eanm advanced course on diagnostic and therapeutic applications of nuclear medicine in oncology 2024 essen esmo preceptorship course 22 may 2024 helsinki finland esmo preceptorship on nsclc 2024 helsinki workshop courses 15 jun 2024 sint michielsgestel netherlands methods in clinical cancer research workshop 2024 discover all esmo meetings video gallery esmo summit latin america 2024 invitation from the esmo president 13 mar 2024 esmo immuno oncology 2024 congress m maio a marabelle and i svane invite you to attend 12 mar 2024 esmogynae24 r sanchez bayona and m kfoury share their experience at this event 29 feb 2024 esmo gastrointestinal cancers congress 2024 an excellent opportunity to network and collaborate 27 feb 2024 esmo 2024 a cervantes r dent k jordan others give powerful reasons to submit your work 27 feb 2024 esmo gastrointestinal cancers congress 2024 reasons to attend 14 feb 2024 esmo course in medical oncology for medical students why should you apply 06 feb 2024 who esmo collaboration plan 2024 2026 06 feb 2024 esmobreast24 reasons to attend this top international congress for the breast cancer community 31 jan 2024 esmo gastrointestinal cancers congress 2024 why you should attend 31 jan 2024 esmo sarcoma and rare cancers 2024 reasons to attend 29 jan 2024 esmo sarcoma and rare cancers 2024 reasons to attend 25 jan 2024 watch all esmo videos career development improve your career path participate in our collegial events with leaders in the field and get the chance to collaborate with prominent european cancer institutions are you looking for a fellowship not offered by esmo or would like to post a fellowship external fellowship esmo examination esmo members the main session of the esmo examination 2023 will be held on saturday 21 october during the esmo congress 2023 read more thinking of applying for an esmo oncology fellowship fellowship programme membership become a member 1...
|